These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 39000461)

  • 1. Macrophages and HLA-Class II Alleles in Multiple Sclerosis: Insights in Therapeutic Dynamics.
    Prapas P; Anagnostouli M
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell receptor V genes in multiple sclerosis: increased use of TCRAV8 and TCRBV5 in MBP-specific clones.
    Offner H; Vandenbark AA
    Int Rev Immunol; 1999; 18(1-2):9-36. PubMed ID: 10614737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
    Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
    J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
    Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leucocyte antigen (HLA) class I and II typing in Belgian multiple sclerosis patients.
    Lysandropoulos AP; Racapé J; Holovska V; Toungouz M
    Acta Neurol Belg; 2017 Mar; 117(1):61-65. PubMed ID: 27797002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DRB1 Val86/Val86 genotype associates with multiple sclerosis in Australian patients.
    Teutsch SM; Bennetts BH; Buhler MM; Heard RN; Stewart GJ
    Hum Immunol; 1999 Aug; 60(8):715-22. PubMed ID: 10439317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
    Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
    J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DM polymorphisms do not associate with multiple sclerosis: an association study with analysis of myelin basic protein T cell specificity.
    Ristori G; Carcassi C; Lai S; Fiori P; Cacciani A; Floris L; Montesperelli C; Di Giovanni S; Buttinelli C; Contu L; Pozzilli C; Salvetti M
    J Neuroimmunol; 1997 Aug; 77(2):181-4. PubMed ID: 9258248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
    Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
    Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Involvement of HLA Class II Alleles in Multiple Sclerosis: A Systematic Review with Meta-analysis.
    De Silvestri A; Capittini C; Mallucci G; Bergamaschi R; Rebuffi C; Pasi A; Martinetti M; Tinelli C
    Dis Markers; 2019; 2019():1409069. PubMed ID: 31781296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility.
    Chao MJ; Barnardo MC; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Montpetit A; Sadovnick AD; Knight JC; Ebers GC
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13069-74. PubMed ID: 18765817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis associated amino acids of polymorphic regions relevant for the HLA antigen binding are confined to HLA-DR2.
    Zipp F; Windemuth C; Pankow H; Dichgans J; Wienker T; Martin R; Müller C
    Hum Immunol; 2000 Oct; 61(10):1021-30. PubMed ID: 11082515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
    Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
    Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class II HLA interactions modulate genetic risk for multiple sclerosis.
    Moutsianas L; Jostins L; Beecham AH; Dilthey AT; Xifara DK; Ban M; Shah TS; Patsopoulos NA; Alfredsson L; Anderson CA; Attfield KE; Baranzini SE; Barrett J; Binder TMC; Booth D; Buck D; Celius EG; Cotsapas C; D'Alfonso S; Dendrou CA; Donnelly P; Dubois B; Fontaine B; Fugger L; Goris A; Gourraud PA; Graetz C; Hemmer B; Hillert J; ; Kockum I; Leslie S; Lill CM; Martinelli-Boneschi F; Oksenberg JR; Olsson T; Oturai A; Saarela J; Søndergaard HB; Spurkland A; Taylor B; Winkelmann J; Zipp F; Haines JL; Pericak-Vance MA; Spencer CCA; Stewart G; Hafler DA; Ivinson AJ; Harbo HF; Hauser SL; De Jager PL; Compston A; McCauley JL; Sawcer S; McVean G
    Nat Genet; 2015 Oct; 47(10):1107-1113. PubMed ID: 26343388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
    Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
    J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
    Cree BA; Rioux JD; McCauley JL; Gourraud PA; Goyette P; McElroy J; De Jager P; Santaniello A; Vyse TJ; Gregersen PK; Mirel D; Hafler DA; Haines JL; Pericak-Vance MA; Compston A; Sawcer SJ; Oksenberg JR; Hauser SL; ;
    PLoS One; 2010 Jun; 5(6):e11296. PubMed ID: 20593013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
    Finn TP; Jones RE; Rich C; Dahan R; Link J; David CS; Chou YK; Offner H; Vandenbark AA
    J Neurosci Res; 2004 Oct; 78(1):100-14. PubMed ID: 15372502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunogenetics of multiple sclerosis. The frequency of HLA-alleles class 1 and 2 is lower in Southern Brazil than in the European population.
    Werneck LC; Lorenzoni PJ; Arndt RC; Kay CS; Scola RH
    Arq Neuropsiquiatr; 2016 Aug; 74(8):607-16. PubMed ID: 27556370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.